• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[丝裂霉素C在制剂长期给药期间癌症患者体内的药代动力学]

[Pharmacokinetics of mitomycin C in cancer patients during prolonged administration of the preparation].

作者信息

Smolianskaia A Z, Spasibina T V

出版信息

Antibiotiki. 1984 May;29(5):391-3.

PMID:6430223
Abstract

The mitomycin C levels in the blood of patients subjected to prolonged intravenous injection of the drug in 200-300 ml of isotonic sodium chloride solution for 15-50 minutes were determined in the microbiological test system consisting of E. coli and 1.5 per cent of agar in the meat-peptone broth with restricted contents of the nutrients. Such administration of the drug usually provided lower blood levels than intravenous injections of the drug in analogous doses. However, the drug renal excretion was also less intensive. It suggested that the drug administered for a prolonged period was more completely absorbed by the host tissues. This was confirmed by much lower blood levels of the drug, when the tumors were large, as compared to those in patients with insignificant residues of the tumor tissue after surgical resections. The curves of mitomycin C distribution in the blood indicate that the pharmacokinetics of the drug in patients with tumors is a multi-factorial function.

摘要

在由大肠杆菌和营养成分受限的肉蛋白胨肉汤中1.5%的琼脂组成的微生物检测系统中,测定了在200 - 300毫升等渗氯化钠溶液中持续静脉注射丝裂霉素C 15 - 50分钟的患者血液中的丝裂霉素C水平。与以类似剂量静脉注射该药物相比,这种给药方式通常会使血液水平较低。然而,药物经肾脏排泄的强度也较小。这表明长时间给药的药物被宿主组织吸收得更完全。这一点在肿瘤较大的患者中得到了证实,与手术切除后肿瘤组织残留较少的患者相比,前者血液中的药物水平要低得多。丝裂霉素C在血液中的分布曲线表明,该药物在肿瘤患者体内的药代动力学是一个多因素函数。

相似文献

1
[Pharmacokinetics of mitomycin C in cancer patients during prolonged administration of the preparation].[丝裂霉素C在制剂长期给药期间癌症患者体内的药代动力学]
Antibiotiki. 1984 May;29(5):391-3.
2
Pharmacokinetics of mitomycin C in patients receiving the drug alone or in combination.
Cancer Treat Rep. 1983 Sep;67(9):805-10.
3
[Blood levels of mitomycin C in patients given by various routes of administration].[不同给药途径患者的丝裂霉素C血药浓度]
Gan To Kagaku Ryoho. 1989 Aug;16(8 Pt 1):2639-44.
4
[Pharmacokinetics of mitomycin C and its derivative (KW-2083)].[丝裂霉素C及其衍生物(KW-2083)的药代动力学]
Gan To Kagaku Ryoho. 1982 Aug;9(8):1362-73.
5
A bioassay to measure cytotoxicity of plasma from patients treated with mitomycin C.一种用于测量接受丝裂霉素C治疗患者血浆细胞毒性的生物测定法。
Cancer Res. 1985 Nov;45(11 Pt 2):5939-43.
6
[Effect of mitomycin C on human gastric and colon carcinomas serially transplanted to nude mice--with special reference to the start of drug administration].丝裂霉素C对连续移植于裸鼠的人胃癌和结肠癌的作用——特别提及给药开始时间
Gan To Kagaku Ryoho. 1982 Apr;9(4):638-45.
7
[Intraabdominal administration of MMC adsorbed on activated carbon for management of carcinomatous peritonitis].[活性炭吸附丝裂霉素腹腔内给药治疗癌性腹膜炎]
Gan To Kagaku Ryoho. 1984 Aug;11(8):1550-6.
8
[Pharmacokinetics of mitomycin C (MMC) after infusion into the bronchial artery].[丝裂霉素C(MMC)经支气管动脉注入后的药代动力学]
Gan To Kagaku Ryoho. 1986 Apr;13(4 Pt 1):1086-8.
9
[5-Fluorouracil concentration in various tissues from cancer patients after oral administration of 5-fluorouracil].
Gan To Kagaku Ryoho. 1984 May;11(5):1037-48.
10
[Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-tegafur combination therapy with or without levamisole. 1].左旋咪唑在胃癌术后辅助免疫化疗中的作用——丝裂霉素-替加氟联合疗法加或不加左旋咪唑的随机对照研究。1
Gan To Kagaku Ryoho. 1982 Dec;9(12):2133-47.